Stereotactic Body Radiation Therapy for Re-irradiation of Persistent or Recurrent Non-Small Cell Lung Cancer (original) (raw)
Clinical and Dosimetric Predictors of Radiation Pneumonitis in a Large Series of Patients Treated With Stereotactic Body Radiation Therapy to the Lung
S. Sarangkasiri
International Journal of Radiation Oncology*Biology*Physics, 2013
View PDFchevron_right
Dose escalation with stereotactic body radiation therapy boost for locally advanced non small cell lung cancer
Nadim Nasr
Radiation Oncology, 2013
View PDFchevron_right
Dose-Volume Predictors of Radiation Pneumonitis After Lung Stereotactic Body Radiation Therapy (SBRT): Implications for Practice and Trial Design
Anthony Yip
Cureus, 2020
View PDFchevron_right
Comparison of clinical, tumour-related and dosimetric factors in grade 0-1, grade 2 and grade 3 radiation pneumonitis after stereotactic body radiotherapy for lung tumours
Naoko Sanuki
British Journal of Radiology, 2012
View PDFchevron_right
Stereotactic Body Radiation Therapy as Salvage for Intrathoracic Recurrence in Patients With Previously Irradiated Locally Advanced Non–Small Cell Lung Cancer
Shiao Woo
American Journal of Clinical Oncology, 2016
View PDFchevron_right
Factors affecting post-treatment radiation-induced lung disease in patients receiving stereotactic body radiotherapy to lung
Faruk Zorlu
Radiation and Environmental Biophysics, 2020
View PDFchevron_right
Re-irradiation in lung disease by SBRT: a retrospective, single institutional study
Donatella Caivano
Radiation Oncology
View PDFchevron_right
Analysis of Dose Distribution and Risk of Pneumonitis in Stereotactic Body Radiation Therapy for Centrally Located Lung Tumors
D. Kannarunimit
Technology in Cancer Research & Treatment, 2015
View PDFchevron_right
Toxicity after reirradiation of pulmonary tumours with stereotactic body radiotherapy
Peter Wersäll
Radiotherapy and Oncology, 2011
View PDFchevron_right
A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis
Lionel Falchero
Radiotherapy and Oncology, 2004
View PDFchevron_right
Safety and Tolerability of SBRT after High-Dose External Beam Radiation to the Lung
Kathryn Nelson, Paul Brown, Heather Bauer, Sean Park
Frontiers in oncology, 2014
View PDFchevron_right
Excessive Toxicity When Treating Central Tumors in a Phase II Study of Stereotactic Body Radiation Therapy for Medically Inoperable Early-Stage Lung Cancer
Constantin Yiannoutsos
Journal of Clinical Oncology, 2006
View PDFchevron_right
Lung stereotactic body radiation therapy (SBRT) delivered over 4 or 11days: A comparison of acute toxicity and quality of life
Fiona Lochray
Radiotherapy and Oncology, 2013
View PDFchevron_right
Stereotactic body radiotherapy using a radiobiology-based regimen for stage I nonsmall cell lung cancer
Yuta Shibamoto
Cancer, 2011
View PDFchevron_right
Stereotactic Body Radiation Therapy in Centrally and Superiorly Located Stage I or Isolated Recurrent Non–Small-Cell Lung Cancer
Reza Mehran
International Journal of Radiation Oncology Biology Physics, 2008
View PDFchevron_right
Individualized Radical Radiotherapy of Non–Small-Cell Lung Cancer Based on Normal Tissue Dose Constraints: A Feasibility Study
Angela Van Baardwijk, Liesbeth Boersma, Geert Bosmans
International Journal of Radiation Oncology*Biology*Physics, 2008
View PDFchevron_right
Stereotactic Body Radiation Therapy for Patients With Lung Cancer Previously Treated With Thoracic Radiation
A. Miyakawa, Yasuo Matsumoto
International Journal of Radiation Oncology*Biology*Physics, 2010
View PDFchevron_right
Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: An updated retrospective study on local failure and survival rates
Olfred Hansen
Acta Oncologica, 2013
View PDFchevron_right
Radiation pneumonitis in patients treated for malignant pulmonary lesions with hypofractionated radiation therapy
H Shirato
Radiotherapy and Oncology, 2009
View PDFchevron_right
Long term outcome after 48 Gy stereotactic ablative body radiotherapy for peripheral stage I non-small cell lung cancer
Vincent Remouchamps
BMC Cancer, 2019
View PDFchevron_right
Stereotactic body radiotherapy (SBRT) in central non-small cell lung cancer (NSCLC): solid evidence or "no-go"?
José Belderbos
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2013
View PDFchevron_right
New dose constraint reduces radiation-induced fatal pneumonitis in locally advanced non-small cell lung cancer patients treated with intensity-modulated radiotherapy
Lone Hoffmann
Acta Oncologica, 2015
View PDFchevron_right
Stereotactic Body Radiation Therapy for Patients with Pulmonary Interstitial Change: High Incidence of Fatal Radiation Pneumonitis in a Retrospective Multi-Institutional Study
Yasuo Matsumoto
Cancers, 2018
View PDFchevron_right
A Comparison of Two Stereotactic Body Radiation Fractionation Schedules for Medically Inoperable Stage I Non-small Cell Lung Cancer
Chandana Reddy
Journal of Thoracic Oncology, 2009
View PDFchevron_right
Simple Factors Associated With Radiation-Induced Lung Toxicity After Stereotactic Body Radiation Therapy of the Thorax: A Pooled Analysis of 88 Studies
SHIVA DAS
International Journal of Radiation Oncology*Biology*Physics, 2016
View PDFchevron_right
Clinical Outcome of Stereotactic Body Radiotherapy (SBRT) for Metastatic Lung Tumors using a Radiobiology-based Regimen
Yuta Shibamoto
International Journal of Radiation Oncology*Biology*Physics, 2011
View PDFchevron_right
Stereotactic body radiation therapy for early-stage non-small-cell lung cancer
Simon Lo
Expert Review of Anticancer Therapy, 2008
View PDFchevron_right
Clinical Outcomes After Lung Stereotactic Body Radiation Therapy in Patients With or Without a Prior Lung Resection
Joseph Killoran
American journal of clinical oncology, 2016
View PDFchevron_right
A Comparison of Two Stereotactic Body Radiation Fractionation Schedules for Medically Inoperable Stage I Non-small Cell Lung Cancer: The Cleveland Clinic Experience
Chandana Reddy
Journal of Thoracic Oncology, 2009
View PDFchevron_right
The Search for Optimal Stereotactic Body Radiotherapy Dose in Inoperable, Centrally Located Non–Small-Cell Lung Cancer Continues
Steven Schild
Journal of Clinical Oncology, 2019
View PDFchevron_right
Ipsilateral lung dose volume parameters predict radiation pneumonitis in addition to classical dose volume parameters in locally advanced NSCLC treated with combined modality therapy
Sushma Agrawal
South Asian Journal of Cancer, 2014
View PDFchevron_right
Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer
Su-min Zhou
International Journal of Radiation Oncology*Biology*Physics, 2001
View PDFchevron_right
Stereotactic body radiotherapy for chronic obstructive pulmonary disease patients undergoing or eligible for long-term domiciliary oxygen therapy
Naoko Sanuki
Journal of Radiation Research, 2015
View PDFchevron_right
Safety and Efficacy of Stereotactic Body Radiotherapy for Stage I Non–Small-Cell Lung Cancer in Routine Clinical Practice
Peter Gerszten
Journal of Thoracic Oncology, 2013
View PDFchevron_right
Risk factors for radiation pneumonitis after stereotactic radiation therapy for lung tumours: clinical usefulness of the planning target volume to total lung volume ratio
Chihaya Koriyama
The British journal of radiology, 2018
View PDFchevron_right